Publication: 3237

Impact of Adjuvant Trastuzumab on Locoregional Failure Rates in the Randomized Clinical Trial: NCCTG N9831 (Alliance) Study
      QxMD      Google Scholar   
Citation:
Cancer vol 126 (24) 5239-5246
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
10
Parents:
658   3059  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Genentech  
Grants:
U10CA180821, U10CA180882, UG1CA233253, UG1CA233328, UG1CA232760, U10CA180820, U10CA180828 (ECOG-ACRIN), U10CA180888 (SWOG)  
Corr. Author:
 
Authors:
                       
Networks:
LAPS-MN026, LAPS-NC010, PCRC, PR028   
Study
NCCTG-N9831
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Article